MaaT Pharma SA

EPA:MAAT.PA

7.8 (EUR) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 31.1531.1524.2824.2835.08635.08635.24835.24838.39638.39643.30443.30515.31515.31519.91319.913-5.411
Short Term Investments 000.0340.0340.8170.0410.0630.0630.1080.10800000010.822
Cash and Short Term Investments 31.1531.1524.2824.31435.90335.12735.31135.31138.50438.50443.30443.30515.31515.31519.91319.9135.411
Net Receivables 6.666.666.2055.16410.7237.2416.6024.2380.3593.8280.3882.3913.8342.7192.2411.6530
Inventory 0.1790.1790.190.190.0750.0750.0470.0470.0650.0650.0330.0330.0420.042-0.09700
Other Current Assets 1.6591.6591.3192.3260.1074.3650.1642.5280.1661.7490.1331.5410.5191.6340.1360.6270
Total Current Assets 40.64640.64631.99431.99446.80846.80842.12442.12444.14644.14647.26947.2719.7119.7122.19322.1935.411
Non-Current Assets:
Property, Plant & Equipment, Net 8.5228.5229.1729.1721.2791.2790.9660.9661.041.041.1071.1071.1181.1181.0971.0970
Goodwill 00000000000000000
Intangible Assets 1.3171.3171.3431.3431.2541.2541.21.21.131.130.8060.8060.8850.8850.750.750
Goodwill and Intangible Assets 1.3171.3171.3431.3431.2541.2541.21.21.131.130.8060.8060.8850.8850.750.750
Long Term Investments 0.200.4220.20.4380.30.4360.30.2390.10.2380.10.2370.10.2370.10
Tax Assets -0.20-1.3430-0.4380-0.4360-0.2390-0.2380-0.2370-0.23700
Other Non-Current Assets 0.4380.4381.3430.2220.4390.1390.4360.1360.2390.1390.2370.1370.2370.1370.2360.136-5.411
Total Non-Current Assets 10.27710.27710.93710.9372.9722.9722.6022.6022.4092.4092.152.152.242.242.0832.083-5.411
Total Assets 50.92350.92342.93142.93149.7849.7844.72644.72646.55546.55549.4249.4221.9521.9524.27624.2760
Liabilities & Equity:
Current Liabilities:
Account Payables 5.7045.7046.3496.3493.563.564.5074.5073.7523.7522.4722.4722.8272.8271.4041.4040
Short Term Debt 7.1077.1073.4552.2236.0446.0432.9872.7742.4372.2441.2541.061.0030.9050.8610.7780
Tax Payables 000.05700.08600.04700.10700.03400.02300.03100
Deferred Revenue 1.5181.5180.05701.322000000000000
Other Current Liabilities 0.3921.911.6612.950.371.6931.7231.9361.5751.7680.9771.1710.5940.6920.5940.6770
Total Current Liabilities 14.72114.72111.52211.52211.29611.2969.2179.2177.7647.7644.7034.7034.4244.4242.8592.8590
Non-Current Liabilities:
Long Term Debt 4.4134.4135.42510.626.936.938.3758.3755.8525.8524.5524.5524.9184.9185.2155.2150
Deferred Revenue Non-Current 00000000000000000
Deferred Tax Liabilities Non-Current 00000000000000000
Other Non-Current Liabilities 6.1786.1785.5180.3230.2680.2680.3230.3230.3370.3360.3090.3090.3070.3080.2650.2650
Total Non-Current Liabilities 10.59110.59110.94310.9437.1987.1988.6988.6986.1896.1884.8614.8615.2255.2265.485.480
Total Liabilities 25.31225.31222.46522.46518.49418.49417.91517.91513.95313.9529.5649.5649.6499.658.3398.3390
Equity:
Preferred Stock 35.19635.19600000000000.0010000
Common Stock 1.3921.3921.1621.1621.1591.1590.9940.9940.9890.9890.9880.9880.6590.6590.6590.6590
Retained Earnings -10.976-10.976-18.073-17.857-7.209-7.209-12.507-12.37-6.626-6.626-7.596-7.596-3.104-3.104-4.627-4.6270
Accumulated Other Comprehensive Income/Loss -0.001-0.001-0-000000.0010.00100-0.001-0.001-0-0-4.496
Other Total Stockholders Equity -035.19637.37737.16137.33637.33638.32438.18738.23838.23946.46446.46414.74614.74619.90519.9050
Total Shareholders Equity 25.61125.61120.46620.46631.28631.28626.81126.81132.60232.60339.85639.85612.30112.315.93715.937-4.496
Total Equity 25.61125.61120.46620.46631.28631.28626.81126.81132.60232.60339.85639.85612.30112.315.93715.937-4.496
Total Liabilities & Shareholders Equity 50.92350.92342.93142.93149.7849.7844.72644.72646.55546.55549.4249.4221.9521.9524.27624.276-4.496